Shanwaishan disclosed that major shareholder Hunan Xiangjiang Big Health Venture Capital Partnership plans to reduce its holding by no more than 18.0319 million shares through block trading, representing 4.03% of the company's total share capital. Based on the latest closing price of 11.11 yuan, the stake is worth about 200 million yuan. The reduction window runs from September 3 to December 2, 2026, with the sale price determined by market prices at the time of execution. This is the shareholder's third reduction plan in the past year, after two previous reductions totaling about 3.3675 million shares. The announcement shows that Big Health and its concert parties together hold about 40.2697 million shares, or 9.00% of total share capital, and this reduction will not lead to a change in company control. Shanwaishan's share price has risen first and fallen later this year, hitting an intra-year high of 18.47 yuan, while the latest closing price is down more than 20% from the start of the year.
SWS Hemodialysis Care Co. Ltd. AMajor shareholder plans to reduce stake by up to 4.03%, worth about 200 million yuan, which is negative for the stock.
